Attovia Therapeutics Revenue

Biotechnology Research • 1091 Industrial Rd, Suite 310, United States • 21-50 Employees

Attovia Therapeutics revenue & valuation

Annual revenue	$4,021,085
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,900,000
Total funding	$255,000,000

Key Contacts at Attovia Therapeutics

Hangjun Zhan

Chief Technology Officer

Tao Fu

Chief Executive Officer

Jing Zhang

Associate Director Of Biology

Meagan Vaughn

Director Clinical Science

Ming Xu

Senior Director, Finance And Ops

Thea Hawkins

Director Of Contracting

Adela Hasa Moreno

Regulatory Affairs, Sr. Director

Company overview

Headquarters	1091 Industrial Rd, Suite 310, San Carlos, California 94070, US
Phone number	+15103995001
Website	attovia.com
NAICS	541714
Founded	2023
Employees	21-50
Socials

Attovia Therapeutics Email Formats

Attovia Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@attovia.com), used 83.9% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@attovia.com	83.9%
{first name}{last name}	johndoe@attovia.com	12.9%
{last name}{last name}	doedoe@attovia.com	3.2%

About Attovia Therapeutics

Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases. We leverage ATTOBODY™, our proprietary biologics platform, to generate potentially first-in-class and best-in-class multi-specifics. ATTOBODIES utilize spatial positioning technology to achieve biparatopic target engagement. The biparatopic binding mode of ATTOBODIES results in ultra-high affinity, which translates to best-in-class potency in biologic activity. ATTOBODIES offer unconstrained engineering, making them an ideal modality for the development of multi-specific biologics, with tunable half-life translating to the potential for quarterly or less frequent dosing in patients. The high-throughput, evolution-based ATTOBODY discovery platform delivers a high degree of diversity at industry-leading speed, accelerating and de-risking therapeutics development, offering the potential to become the next-generation modality of choice. Learn more at www.attovia.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Attovia Therapeutics has 16 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Attovia Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-07-20	4	$60,000,000
2024-06-09	5	$105,000,000
2025-05-15	6	$90,000,000

Funding Insights

$255,000,000

Total funding amount

$90,000,000

Most recent funding amount

Number of funding rounds

Attovia Therapeutics Tech Stack

Discover the technologies and tools that power Attovia Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Swiper

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

Attovia Therapeutics is located in 1091 Industrial Rd, Suite 310, US.

You can reach Attovia Therapeutics at +15103995001.

Attovia Therapeutics generates an estimated annual revenue of $4,021,085. This revenue figure reflects the company's market position and business performance in its industry.

Attovia Therapeutics has an estimated valuation of $12,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Attovia Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Attovia Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Attovia Therapeutics has raised a total of $255,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Attovia Therapeutics

Hangjun Zhan

Chief Technology Officer

Tao Fu

Chief Executive Officer

Jing Zhang

Associate Director Of Biology

Meagan Vaughn

Director Clinical Science

Ming Xu

Senior Director, Finance And Ops

Thea Hawkins